• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Within- and between-subject variations in pharmacokinetic parameters of ethanol by analysis of breath, venous blood and urine.通过分析呼气、静脉血和尿液来研究乙醇药代动力学参数的个体内和个体间变异。
Br J Clin Pharmacol. 2000 May;49(5):399-408. doi: 10.1046/j.1365-2125.2000.00194.x.
2
Do ethanol and deuterium oxide distribute into the same water space in healthy volunteers?乙醇和重水在健康志愿者体内是否分布于同一水空间?
Alcohol Clin Exp Res. 2001 Oct;25(10):1423-30. doi: 10.1097/00000374-200110000-00004.
3
Role of variability in explaining ethanol pharmacokinetics: research and forensic applications.变异性在解释乙醇药代动力学中的作用:研究与法医学应用。
Clin Pharmacokinet. 2003;42(1):1-31. doi: 10.2165/00003088-200342010-00001.
4
Ethanol pharmacokinetics in white women: nonlinear model fitting versus zero-order elimination analyses.白人女性体内乙醇的药代动力学:非线性模型拟合与零级消除分析
Alcohol Clin Exp Res. 2000 Sep;24(9):1353-62.
5
Population pharmacokinetics of multiple alcohol intake in humans.人群中多次饮酒的药代动力学研究。
Alcohol. 2013 Mar;47(2):159-65. doi: 10.1016/j.alcohol.2012.12.012. Epub 2013 Jan 8.
6
Population pharmacokinetics of ethanol in drinking drivers using breath measures.
Ther Drug Monit. 2004 Aug;26(4):391-400. doi: 10.1097/00007691-200408000-00009.
7
Between-subject and within-subject variations in the pharmacokinetics of ethanol.乙醇药代动力学的个体间和个体内变异
Br J Clin Pharmacol. 1994 May;37(5):427-31. doi: 10.1111/j.1365-2125.1994.tb05709.x.
8
Concentration-time profiles of ethanol in arterial and venous blood and end-expired breath during and after intravenous infusion.静脉输注期间及之后动脉血、静脉血和终末呼出气体中乙醇的浓度-时间曲线。
J Forensic Sci. 1997 Nov;42(6):1088-94.
9
Eating a meal increases the clearance of ethanol given by intravenous infusion.
Alcohol Alcohol. 1994 Nov;29(6):673-7.
10
Clinical pharmacokinetics of ethanol.乙醇的临床药代动力学
Clin Pharmacokinet. 1987 Nov;13(5):273-92. doi: 10.2165/00003088-198713050-00001.

引用本文的文献

1
A physiologically-based digital twin for alcohol consumption-predicting real-life drinking responses and long-term plasma PEth.一种基于生理学的酒精消费数字孪生模型——用于预测现实生活中的饮酒反应和长期血浆磷酸乙醇(PEth)水平。
NPJ Digit Med. 2024 May 3;7(1):112. doi: 10.1038/s41746-024-01089-6.
2
Blood alcohol concentration in the clinical laboratory: a narrative review of the preanalytical phase in diagnostic and forensic testing.临床实验室中的血液酒精浓度:诊断和法医检测中分析前阶段的叙述性综述。
Biochem Med (Zagreb). 2024 Feb 15;34(1):010501. doi: 10.11613/BM.2024.010501. Epub 2023 Dec 15.
3
Pharmacokinetic Analysis of Ethanol in a Human Study: New Modification of Mathematic Model.人体研究中乙醇的药代动力学分析:数学模型的新修正
Toxics. 2023 Sep 20;11(9):793. doi: 10.3390/toxics11090793.
4
Lactate kinetics in ICU patients using a bolus of C-labeled lactate.使用一剂 C 标记乳酸盐的重症监护病房患者的乳酸动力学
Crit Care. 2020 Feb 10;24(1):46. doi: 10.1186/s13054-020-2753-6.
5
Fetal alcohol-spectrum disorders: identifying at-risk mothers.胎儿酒精谱系障碍:识别高危母亲。
Int J Womens Health. 2016 Jul 21;8:311-23. doi: 10.2147/IJWH.S85403. eCollection 2016.
6
Pattern Recognition in Pharmacokinetic Data Analysis.药代动力学数据分析中的模式识别
AAPS J. 2016 Jan;18(1):47-63. doi: 10.1208/s12248-015-9817-6. Epub 2015 Sep 3.
7
In silico Models of Alcohol Dependence and Treatment.酒精依赖与治疗的计算机模拟模型
Front Psychiatry. 2012 Feb 3;3:4. doi: 10.3389/fpsyt.2012.00004. eCollection 2012.
8
Comparison of spectroscopically measured tissue alcohol concentration to blood and breath alcohol measurements.比较光谱法测量的组织酒精浓度与血液和呼气酒精测量值。
J Biomed Opt. 2009 Sep-Oct;14(5):054039. doi: 10.1117/1.3253353.
9
ADH single nucleotide polymorphism associations with alcohol metabolism in vivo.抗利尿激素单核苷酸多态性与体内酒精代谢的关联。
Hum Mol Genet. 2009 Apr 15;18(8):1533-42. doi: 10.1093/hmg/ddp060. Epub 2009 Feb 4.
10
Physiologically based pharmacokinetic (PBPK) models for ethanol.乙醇的基于生理的药代动力学(PBPK)模型。
IEEE Trans Biomed Eng. 2008 Dec;55(12):2691-700. doi: 10.1109/TBME.2008.919132.

本文引用的文献

1
The kinetics of alcohol elimination in man.人体中酒精消除的动力学。
Acta Pharmacol Toxicol (Copenh). 1958;14(3):265-89. doi: 10.1111/j.1600-0773.1958.tb01164.x.
2
Pharmacokinetics of Ethanol in Arterial and Venous Blood and in End-Expired Breath during Vasoconstriction and Vasodilation.血管收缩和血管舒张期间乙醇在动脉血、静脉血及终末呼气中的药代动力学
Am J Ther. 1995 Dec;2(12):954-961. doi: 10.1097/00045391-199512000-00009.
3
Rate of Distribution of Eethanol into the Total Body Water.
Am J Ther. 1995 Jan;2(1):50-56. doi: 10.1097/00045391-199501000-00010.
4
Problems in pharmacokinetic analysis of alcohol disposition: a trial of the Bayesian least-squares method.
Alcohol Clin Exp Res. 1996 Feb;20(1 Suppl):2A-6A. doi: 10.1111/j.1530-0277.1996.tb01717.x.
5
Disposition and first-pass metabolism of ethanol in humans: is it gastric or hepatic and does it depend on gender?乙醇在人体中的处置及首过代谢:是胃部还是肝脏起作用,且是否取决于性别?
Clin Pharmacol Ther. 1996 May;59(5):503-13. doi: 10.1016/S0009-9236(96)90178-2.
6
Ranitidine increases the bioavailability of imbibed alcohol by accelerating gastric emptying.
Life Sci. 1996;58(6):511-8. doi: 10.1016/0024-3205(95)02316-x.
7
In vivo induction of hepatic P4502E1 by ethanol: role of increased enzyme synthesis.乙醇对肝脏P4502E1的体内诱导作用:酶合成增加的作用。
Arch Biochem Biophys. 1993 Jul;304(1):209-18. doi: 10.1006/abbi.1993.1341.
8
The critical role of the rate of ethanol absorption in the interpretation of studies purporting to demonstrate gastric metabolism of ethanol.乙醇吸收速率在旨在证明乙醇胃代谢的研究解读中的关键作用。
J Pharmacol Exp Ther. 1994 Apr;269(1):297-304.
9
First-pass metabolism of ethanol is predominantly gastric.乙醇的首过代谢主要发生在胃部。
Alcohol Clin Exp Res. 1993 Dec;17(6):1337-44. doi: 10.1111/j.1530-0277.1993.tb05250.x.
10
Between-subject and within-subject variations in the pharmacokinetics of ethanol.乙醇药代动力学的个体间和个体内变异
Br J Clin Pharmacol. 1994 May;37(5):427-31. doi: 10.1111/j.1365-2125.1994.tb05709.x.

通过分析呼气、静脉血和尿液来研究乙醇药代动力学参数的个体内和个体间变异。

Within- and between-subject variations in pharmacokinetic parameters of ethanol by analysis of breath, venous blood and urine.

作者信息

Norberg A, Gabrielsson J, Jones A W, Hahn R G

机构信息

Department of Anaesthesia and Intensive Care, Huddinge University Hospital, Huddinge, Sweden.

出版信息

Br J Clin Pharmacol. 2000 May;49(5):399-408. doi: 10.1046/j.1365-2125.2000.00194.x.

DOI:10.1046/j.1365-2125.2000.00194.x
PMID:10792196
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2014954/
Abstract

AIMS

To evaluate the prerequisites for using ethanol dilution to estimate total body water, we studied the within- and between-subject variation in the parameter estimates of a two-compartment model for ethanol pharmacokinetics with parallel Michaelis-Menten and first-order renal elimination. Because sampling of breath might be preferable in some clinical situations the parameter estimates derived from breath and venous blood were compared.

METHODS

On two occasions, ethanol 0.4 g kg-1 was given by intravenous infusion to 16 volunteers after they had fasted overnight. The proposed model was fitted by means of nonlinear regression to concentration-time data measured in the breath, venous blood and urine during 360 min. The model contained six parameters: Vmax and Km (Michaelis-Menten elimination constants), CLd (intercompartmental distribution parameter), VC and VT (volumes of the central and tissue compartment, respectively) and CLR (renal clearance). The volume of distribution, Vss, was calculated as the sum of VC and VT.

RESULTS

The mean +/- total s.d. of the parameter estimates derived from blood data were Vmax 95 +/- 25 mg min-1, Km 27 +/- 19 mg l-1, CLd 809 +/- 232 ml min-1, VC 14.5 +/- 4.3 l, VT 21. 2 +/- 4.4 l, CLR 3.6 +/- 2.0 ml min-1 and Vss 35.8 +/- 4.3 l. The variation within subjects amounted to 3%, 9%, 21%, 21%, 17%, 26% and 2%, respectively, of the total variation. Breath samples were associated with a similar or lower variation than blood, both within and between subjects. About 1.5% of the infused ethanol was recovered in the urine.

CONCLUSIONS

The low within-subject variation of the key parameter Vss (only 2%) suggests that ethanol dilution analysed by the pharmacokinetic model applied here may be used as an index of the total body water. Breath samples yielded at least as good reproducibility in the model parameters as venous blood.

摘要

目的

为评估使用乙醇稀释法估算总体水的前提条件,我们研究了具有平行米氏(Michaelis-Menten)和一级肾清除的乙醇药代动力学二室模型参数估计值的个体内和个体间变异。由于在某些临床情况下采集呼气样本可能更可取,因此对从呼气和静脉血得出的参数估计值进行了比较。

方法

16名志愿者隔夜禁食后,分两次静脉输注0.4 g/kg乙醇。通过非线性回归将所提出的模型拟合到360分钟内呼气、静脉血和尿液中测得的浓度-时间数据。该模型包含六个参数:Vmax和Km(米氏消除常数)、CLd(室间分布参数)、VC和VT(分别为中央室和组织室的容积)以及CLR(肾清除率)。分布容积Vss计算为VC与VT之和。

结果

从血液数据得出的参数估计值的均值±总标准差为:Vmax 95±25 mg/min,Km 27±19 mg/l,CLd 809±232 ml/min,VC 14.5±4.3 l,VT 21.2±4.4 l,CLR 3.6±2.0 ml/min,Vss 35.8±4.3 l。个体内变异分别占总变异的3%、9%、21%、21%、17%、26%和2%。无论是个体内还是个体间,呼气样本的变异与血液相似或更低。约1.5%的输注乙醇在尿液中回收。

结论

关键参数Vss的个体内变异较低(仅2%),表明此处应用的药代动力学模型分析的乙醇稀释法可作为总体水的指标。呼气样本在模型参数方面产生的重现性至少与静脉血一样好。